Vanderbilt, Meharry researchers find Moderna vaccine safe for kids 6-11

Vanderbilt University Medical Center and Meharry Medical College researchers helped determine that Moderna’s COVID-19 vaccine is safe and effective for children ages 6 to 11. Earlier this week, Moderna asked for approval from the U.S. Food and Drug Administration to offer the vaccine to this age group. 

A national clinical trial was co-led by C. Buddy Creech, director of the Vanderbilt Vaccine Research Center, and Vladimir Berthaud with Meharry Medical College. Evan Anderson with Emory University School of Medicine in Atlanta was also a co-leader.